Susquehanna International Group, LLP Ocular Therapeutix, Inc Put Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Put Options

29 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$6.45 - $9.23 $49,665 - $71,071	-7,700 Reduced 8.77%	80,100 $696,000
Q2 2024 Aug 15, 2024	SELL	$4.2 - $8.69 $997,080 - $2.06 Million	-237,400 Reduced 73.0%	87,800 $600,000
Q1 2024 May 07, 2024	BUY	$3.85 - $10.93 $880,880 - $2.5 Million	228,800 Added 237.34%	325,200 $2.96 Million
Q4 2023 Feb 14, 2024	BUY	$2.08 - $4.52 $103,376 - $224,643	49,700 Added 106.42%	96,400 $429,000
Q3 2023 Nov 14, 2023	SELL	$3.14 - $5.04 $367,380 - $589,680	-117,000 Reduced 71.47%	46,700 $146,000
Q2 2023 Aug 11, 2023	SELL	$4.6 - $7.64 $203,779 - $338,452	-44,300 Reduced 21.3%	163,700 $844,000
Q1 2023 May 16, 2023	BUY	$2.79 - $6.27 $91,233 - $205,029	32,700 Added 18.65%	208,000 $1.1 Million
Q4 2022 Feb 14, 2023	SELL	$2.61 - $4.41 $269,352 - $455,112	-103,200 Reduced 37.06%	175,300 $492,000
Q3 2022 Nov 14, 2022	BUY	$4.09 - $6.5 $957,878 - $1.52 Million	234,200 Added 528.67%	278,500 $1.16 Million
Q2 2022 Aug 15, 2022	SELL	$3.01 - $5.22 $370,531 - $642,582	-123,100 Reduced 73.54%	44,300 $178,000
Q1 2022 May 16, 2022	SELL	$4.83 - $7.35 $290,766 - $442,470	-60,200 Reduced 26.45%	167,400 $829,000
Q4 2021 Feb 14, 2022	SELL	$6.16 - $12.07 $2.12 Million - $4.15 Million	-343,800 Reduced 60.17%	227,600 $1.59 Million
Q3 2021 Nov 15, 2021	BUY	$9.7 - $14.34 $1.98 Million - $2.93 Million	204,400 Added 55.69%	571,400 $5.71 Million
Q2 2021 Aug 11, 2021	BUY	$13.43 - $19.16 $1.29 Million - $1.84 Million	95,800 Added 35.32%	367,000 $5.2 Million
Q1 2021 May 17, 2021	BUY	$15.82 - $22.11 $2.67 Million - $3.73 Million	168,700 Added 164.59%	271,200 $4.45 Million
Q4 2020 Feb 16, 2021	SELL	$7.91 - $22.95 $821,058 - $2.38 Million	-103,800 Reduced 50.32%	102,500 $2.12 Million
Q3 2020 Nov 16, 2020	SELL	$7.36 - $9.87 $83,168 - $111,530	-11,300 Reduced 5.19%	206,300 $1.57 Million
Q2 2020 Aug 14, 2020	BUY	$4.67 - $8.95 $656,135 - $1.26 Million	140,500 Added 182.23%	217,600 $1.81 Million
Q1 2020 May 15, 2020	BUY	$3.95 - $7.4 $206,585 - $387,020	52,300 Added 210.89%	77,100 $382,000
Q4 2019 Feb 14, 2020	SELL	$2.57 - $4.73 $27,499 - $50,611	-10,700 Reduced 30.14%	24,800 $98,000
Q3 2019 Nov 14, 2019	SELL	$3.04 - $5.32 $51,680 - $90,440	-17,000 Reduced 32.38%	35,500 $108,000
Q2 2019 Aug 14, 2019	BUY	$2.46 - $4.52 $86,592 - $159,103	35,200 Added 203.47%	52,500 $231,000
Q1 2019 May 15, 2019	SELL	$3.51 - $4.77 $164,268 - $223,235	-46,800 Reduced 73.01%	17,300 $69,000
Q4 2018 Feb 14, 2019	SELL	$3.87 - $7.11 $92,493 - $169,929	-23,900 Reduced 27.16%	64,100 $255,000
Q3 2018 Nov 14, 2018	BUY	$5.42 - $6.99 $240,648 - $310,356	44,400 Added 101.83%	88,000 $605,000
Q2 2018 Aug 14, 2018	SELL	$5.99 - $8.17 $222,828 - $303,924	-37,200 Reduced 46.04%	43,600 $294,000
Q1 2018 May 15, 2018	BUY	$4.66 - $7.08 $15,378 - $23,364	3,300 Added 4.26%	80,800 $526,000
Q4 2017 Feb 14, 2018	SELL	$3.73 - $6.37 $135,026 - $230,594	-36,200 Reduced 31.84%	77,500 $345,000
Q3 2017 Nov 14, 2017	BUY	$5.28 - $6.88 $600,336 - $782,256	113,700	113,700 $703,000

Others Institutions Holding OCUL

# of Institutions

172

Shares Held

138M

Call Options Held

150K

Put Options Held

225K

View Full List

About OCULAR THERAPEUTIX, INC

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $764M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

More about OCUL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account